Press releases
BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
3 Apr 24
News, Legal, Press Releases
BioCorRx Reports Business Update for 2023
2 Apr 24
Press Releases
BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
28 Feb 24
Press Releases
BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
8 Feb 24
News, Management, Press Releases